Biotech Umeå

Patent approval results in new employees

Pressmeddelande   •   Feb 25, 2016 07:45 CET

SpinChem AB in Umeå has recently been granted several new patents relating to the construction of its proprietary rotating bed reactors (RBR) and their use in chemical and biological processes. The applications of the RBR technology are numerous. Examples can be found in the production of biodiesel, the production of fermented beverages and the manufacturing of ingredients for pharmaceuticals and cosmetics.

The approved patents show, among other things, how enzymes bound to a solid support, or contained within encapsulated cells, can be made to produce desired molecules more efficiently by creating faster and more efficient transport of components in the solution to the enzymes. Corresponding improvements can also be achieved for ‘chemical clean-up’ processes such as required for industrial water treatment. In all cases the results are expected to generate considerable improvements in processes productivity.

The success of the technology has resulted in SpinChem recruiting additional staff to increase the pace of product development and sales.

"We are investing ahead on all fronts," said Emil Byström, CEO at SpinChem AB. He continues; "Six months ago we hired another product developer and recently we hired a PhD chemist for development of new applications and processes. At the same time we have made great efforts in marketing and sales. We recently launched a new website and are in advanced negotiations with distributors in several countries. The future looks very promising."

Contact CEO Emil Byström +46 70-6892501

About SpinChem AB SpinChem is a privately held company in Umeå, Sweden, that develops innovative rotating bed reactors (RBR) for synthesis, manufacturing and purification in the chemical and biotechnology industries. The company provides solutions from laboratory to production scale for customers worldwide. The RBR technology has been developed in Umeå and is extensively patented by the company.

Biotech Umeå är ett klusterinitiativ med syfte att skapa tillväxt och bättre förutsättningar för regionens life science-företag, i samarbete med regionala, nationella och internationella partners. Umeå-klustret är världsledande inom områden som t.ex. infektionsforskning, skogsbioteknik, metaboliska och neurodegenerativa sjukdomar. Biotech Umeå finansieras av Umeå kommun, Umeå universitet, Region Västerbotten, Västerbottens läns landsting, FOI och EU Europeiska regionala utvecklingsfonden samt är genom finansiering och tillförd kompetens en prioriterad satsning hos Uminova Innovation.Ytterligare information finns på